The author reports a case of topical benzocaine-induced methemoglobinemia. Benzocaine is a topical anesthetic commonly used during minor surgical and cannulation procedures. Although not widely reported, benzocaine has the potential to induce severe or life-threatening methemoglobinemia. Clinical practitioners should be cognizant of this complication associated with benzocaine use and its appropriate management. The following report describes a case of topical benzocaine-induced methemoglobinemia in a 74-year-old, Caucasian woman who had undergone transesophageal echocardiography and who received topical benzocaine for local anesthesia. Ten minutes after the administration of benzocaine, her oxygen saturation levels decreased to 71%, requiring immediate attention. Co-oximetry (multiple wavelength spectrophotometry) measured methemoglobin levels indicated the presence of methemoglobinemia. The patient was subsequently treated with 60 mg of intravenous methylene blue. Within 10 minutes, the patient’s condition had improved. The primary etiology of methemoglobinemia is from exposure to oxidizing agents. Benzocaine is an oxidizing agent commonly used as a topical anesthetic. Topically applied benzocaine, in the patient described here and in other reported cases, produced elevated methemoglobin levels requiring treatment with a reducing agent. Methylene blue, within a specified dosage range, can serve as a reducing agent to reverse the effects of topically applied benzocaine-induced methemoglobinemia.
Bernstein BM. Cyanosis following use of anesthesia (ethylaminobenzoate). Rev Gastroenterol. 1950;17:123-124.
2.
Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999;34:646-656.
3.
Guerriero SE. Methemoglobinemia caused by topical benzocaine. Pharmacotherapy. 1997;17:1030-1040.
4.
Guertler AT, Pearce WA. A prospective evaluation of benzocaine-associated methemoglobinemia in human. Ann Emerg Med. 1994;24:626-630.
5.
Lukens JN. Methemoglobinemia and other disorders accompanied by cyanosis. In: Lee GR, Foerster J, Lukens JN, Paraskevas F, Greer JP, Rodgers GM, eds. Wintrobe’s Clinical Hematology. 10th ed.Baltimore, MD: Williams & Wilkins; 1999:1046-1055.
6.
Ho RT, Nanevicz T, Yee R, et al. Benzocaine-induced methemoglobinemia—two case reports related to transesophageal echocardiography premedication. Cardiovasc Drug Ther. 1998;12:311-312.
7.
Bryson PD. Drugs and toxins causing methemoglobinemia. In: Comprehensive Review in Toxicology for Emergency Clinicians. 3rd ed.Philadelphia, PA: Hemisphere Publishing; 1996: 372-379.
8.
Harvey JW, Keitt AS. Studies of the efficacy and potential hazards of methylene blue therapy in aniline-induced methemoglobinemia. Br J Haemtol. 1983;54:29-41.
9.
Goluboff N, Sheaton R.Methylene blue-induced cyanosis and acute hemolytic anemia complicating the treatment of methemoglobinemia. J Pediatr. 1961;58:86.
10.
Finch CA. Treatment of intracellular methemoglobinemia. Bull N Engl Med Ctr. 1947;9:241-245.
11.
Khan NA, Kruse JA. Methemoglobinemia induced by topical anesthesia: a case report and review. Am J Med Sci. 1999;318:415-418.
12.
Rosen PJ, Johnson C, McGehee WG, et al. Failure of methylene blue treatment in toxic methemoglobinemia: association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med. 1971;75:83-86.
13.
Kirsch IR, Cohen HJ. Heinz body hemolytic anemia from the use of methylene blue in neonates. J Pediatr. 1980;96:276-278.
14.
Harrison MR. Toxic methemoglobinemia: a case of acute nitrobenzene and aniline poisoning treated by exchange transfusion. Anaesthesia. 1977;32:270-272.
